X
National Commodity & Derivatives Exchange (NCDEX)

₹428.00

mrf 0.00%
05 Mar 2026

Listing Status: Active

Connect: •••
•••• ••••
•••
Key Metrics of National Commodity & Derivatives Exchange
  • Market Cap3838.94 Cr.
  • Total Equity Funding$113M in 3 rounds
  • Latest Funding Round$88M, Series B Aug 29, 2025
  • Post Money Valuation$199M as on Oct 07, 2025
  • Annual Revenue₹122 Cr
  • EBITDA₹295 Cr
  • EBITDA Margin241.80%
  • Net Profit₹236 Cr
  • Net Profit Margin193.42%
About the Company

Provider of agricultural derivatives exchange services. It is focused on agricultural and some non-agricultural commodity derivatives. It provides a transparent...

Loading...
Price on BSE Volume

Funding Rounds

Total Rounds: 3 Ncdex

S.No. Date Round Name Amount TTM Revenue Investors & Facilitators
1. Aug 29, 2025 Series B $88M $13.8M
Inst: Tower Research Capital, Groww, Kotak Life, JM Financial, Acacia Partners, Citadel Securities, Zerodha, Rainmatter, InCred Capital, Globe Capital, Share India, Jainam Broking, Marwadi Chandarana Group, JM Financial Products, Findoc, SMC Global Securities, Evergrow Ventures, Singularity Holdings, Excel Stock Broking, Ashika Group, Achintya, Finsol Securities, Arham, Exclusive Build Project, Cheers Consumer Products, Minosha, Antique Limited, KIFS Trade Capital, Monarch Networth Capital, Tipsons Group, Adroitfinancial, Indo Thai, Jaypee Capital, Master Trust, SKI Capital, Evermore, Algoquant Fintech, Mahalaxmi Brokerage India, L7 Group, FE Securities, Altcase, Stockify, Bright Beacon, Sri Professionals, Risify, Vrudev Commodities
Angel: Radhakishan, Viral, Ramesh, Kanchan, Madhusudan, Gopikishan, Amit, Hemchand, Sunil, Paresh, Vijay, Jayesh, Umesh, Kumud, Teena, Nirmala, Suchitra
2. Nov 6, 2013 Series A $7.4M -
Inst: IDFC First Bank
3. Mar 23, 2010 Series A $18.1M -
Inst: NSE, Life Insurance Corporation of India, NABARD, CRISIL, IFFCO, Canara Bank, Shree Renuka Sugars, Punjab National Bank
Angel: Anand

Financial Statements

Revenue - INR (Cr)

Net Profit/Loss - INR (Cr)

Select a year from the tabs

FY 24-25
FY 23-24
FY 22-23
FY 21-22
FY 20-21
FY 19-20
FY 18-19
FY 17-18
FY 16-17
FY 15-16
FY 14-15
FY 13-14
Detailed Income StatementFY 24-25 (in Cr)
122.1
197.0
Total profit before exceptional items, extraordinary items and tax (75.0)
Exceptional items before tax 344.0
Total profit before tax 269.1
42.7
Total profit (loss) for period from continuing operations 226.3
Share of profit (loss) of associates 9.8
Total profit (loss) for period 236.1
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Detailed Balance SheetFY 24-25 (in Cr)
1,245.9
1,245.9
Detailed Cash Flow StatementFY 24-25 (in Cr)
Net cash from / (used in) operating activities 11.8
Net cash from / (used in) investing activities 60.2
Net cash from / (used) in financing activities (7.5)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 64.5
Net increase / (decrease) in cash and cash equivalents 64.5
Cash and cash equivalents at the beginning of the year 97.8
Cash and cash equivalents at the end of the year 162.4
Detailed Income StatementFY 23-24 (in Cr)
136.1
187.2
Total profit before exceptional items, extraordinary items and tax (51.2)
Exceptional items before tax 9.9
Total profit before tax (41.3)
(5.5)
Total profit (loss) for period from continuing operations (35.8)
Share of profit (loss) of associates 8.1
Total profit (loss) for period (27.7)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 23-24 (in Cr)
838.3
838.3
Detailed Cash Flow StatementFY 23-24 (in Cr)
Net cash from / (used in) operating activities (55.4)
Net cash from / (used in) investing activities 96.0
Net cash from / (used) in financing activities (6.4)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 34.2
Net increase / (decrease) in cash and cash equivalents 34.2
Cash and cash equivalents at the beginning of the year 63.7
Cash and cash equivalents at the end of the year 97.8
Detailed Income StatementFY 22-23 (in Cr)
135.6
196.2
Total profit before exceptional items, extraordinary items and tax (60.7)
Exceptional items before tax (5.3)
Total profit before tax (66.0)
(15.6)
Total profit (loss) for period from continuing operations (50.4)
Share of profit (loss) of associates 8.0
Total profit (loss) for period (42.4)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 22-23 (in Cr)
876.0
876.0
Detailed Cash Flow StatementFY 22-23 (in Cr)
Net cash from / (used in) operating activities (96.9)
Net cash from / (used in) investing activities 97.1
Net cash from / (used) in financing activities (8.4)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes (8.2)
Net increase / (decrease) in cash and cash equivalents (8.2)
Cash and cash equivalents at the beginning of the year 71.8
Cash and cash equivalents at the end of the year 63.7
Detailed Income StatementFY 21-22 (in Cr)
154.4
176.9
Total profit before exceptional items, extraordinary items and tax (22.5)
Exceptional items before tax 0
Total profit before tax (22.5)
(4.6)
Total profit (loss) for period from continuing operations (17.9)
Share of profit (loss) of associates 5.6
Total profit (loss) for period (12.3)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 21-22 (in Cr)
931.3
931.3
Detailed Cash Flow StatementFY 21-22 (in Cr)
Net cash from / (used in) operating activities (180.6)
Net cash from / (used in) investing activities 33.7
Net cash from / (used) in financing activities (8.3)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes (155.2)
Net increase / (decrease) in cash and cash equivalents (155.2)
Cash and cash equivalents at the beginning of the year 227.1
Cash and cash equivalents at the end of the year 71.8
Detailed Income StatementFY 20-21 (in Cr)
148.9
172.7
Total profit before exceptional items, extraordinary items and tax (23.8)
Exceptional items before tax (1.0)
Total profit before tax (24.8)
(6.5)
Total profit (loss) for period from continuing operations (18.3)
Share of profit (loss) of associates 3.7
Total profit (loss) for period (14.6)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 20-21 (in Cr)
1,074.2
1,074.2
Detailed Cash Flow StatementFY 20-21 (in Cr)
Net cash from / (used in) operating activities 93.7
Net cash from / (used in) investing activities 48.4
Net cash from / (used) in financing activities (9.8)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 132.2
Net increase / (decrease) in cash and cash equivalents 132.2
Cash and cash equivalents at the beginning of the year 120.7
Cash and cash equivalents at the end of the year 252.9
Detailed Income StatementFY 19-20 (in Cr)
174.6
178.1
Total profit before exceptional items, extraordinary items and tax (3.5)
Exceptional items before tax (3.8)
Total profit before tax (7.2)
(5.0)
Total profit (loss) for period from continuing operations (2.2)
Share of profit (loss) of associates 9.6
Total profit (loss) for period 7.3
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Detailed Balance SheetFY 19-20 (in Cr)
985.2
985.2
Detailed Cash Flow StatementFY 19-20 (in Cr)
Net cash from / (used in) operating activities 67.8
Net cash from / (used in) investing activities (13.7)
Net cash from / (used) in financing activities (11.9)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 42.3
Net increase / (decrease) in cash and cash equivalents 42.3
Cash and cash equivalents at the beginning of the year 78.5
Cash and cash equivalents at the end of the year 120.7
Detailed Income StatementFY 18-19 (in Cr)
193.2
180.3
Total profit before exceptional items, extraordinary items and tax 12.9
Exceptional items before tax 0
Total profit before tax 12.9
(2.0)
Total profit (loss) for period from continuing operations 14.8
Share of profit (loss) of associates 3.2
Total profit (loss) for period 18.1
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Detailed Balance SheetFY 18-19 (in Cr)
828.4
828.4
Detailed Cash Flow StatementFY 18-19 (in Cr)
Net cash from / (used in) operating activities (22.3)
Net cash from / (used in) investing activities 59.0
Net cash from / (used) in financing activities (1.7)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 35.0
Net increase / (decrease) in cash and cash equivalents 35.0
Cash and cash equivalents at the beginning of the year 43.5
Cash and cash equivalents at the end of the year 78.5
Detailed Income StatementFY 17-18 (in Cr)
163.7
171.9
Total profit before exceptional items, extraordinary items and tax (8.2)
Exceptional items before tax 0
Total profit before tax (8.2)
6.2
Total profit (loss) for period from continuing operations (14.4)
Share of profit (loss) of associates 2.9
Total profit (loss) for period (11.5)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 17-18 (in Cr)
826.2
826.2
Detailed Cash Flow StatementFY 17-18 (in Cr)
Net cash from / (used in) operating activities (222.4)
Net cash from / (used in) investing activities 98.4
Net cash from / (used) in financing activities 23.3
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes (100.8)
Net increase / (decrease) in cash and cash equivalents (100.8)
Cash and cash equivalents at the beginning of the year 144.3
Cash and cash equivalents at the end of the year 43.5
Detailed Income StatementFY 16-17 (in Cr)
166.4
156.7
Total profit before exceptional items, extraordinary items and tax 9.7
Exceptional items before tax 9.5
Total profit before tax 19.2
4.8
Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
Total profit (loss) for period from continuing operations 14.5
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Share of profit (loss) of associates 7.8
Total profit (loss) for period 22.3
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Detailed Balance SheetFY 16-17 (in Cr)
975.7
975.7
Detailed Cash Flow StatementFY 16-17 (in Cr)
Net cash from / (used in) operating activities 147.9
Net cash from / (used in) investing activities (44.1)
Net cash from / (used) in financing activities (15.3)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 88.5
Net increase / (decrease) in cash and cash equivalents 88.5
Cash and cash equivalents at the beginning of the year 55.8
Cash and cash equivalents at the end of the year 144.3
Detailed Income StatementFY 15-16 (in Cr)
209.1
137.7
Total profit before prior period items, exceptional items, extraordinary items and tax 71.4
Prior period items before tax 0
Exceptional items before tax 36.3
Total profit before extraordinary items and tax 107.6
Extraordinary items before tax 0
Total profit before tax 107.6
33.3
Total profit (loss) for period from continuing operations 74.3
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period before minority interest 74.3
Profit (loss) of minority interest 0
Share of profit (loss) of associates 0
Total profit (loss) for period 74.3
Pre-tax gain or loss recognised on disposal of assets or settlement of liabilities attributable to discontinuing operations 0
Basic earning per equity share before extraordinary items 0.0
Diluted earnings per equity share before extraordinary items 0.0
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Nominal value of per equity share 0.0
Detailed Balance SheetFY 15-16 (in Cr)
792.2
792.2
Detailed Cash Flow StatementFY 15-16 (in Cr)
Cash flow from operating activities 44.5
Net cash from / (used in) operating activities 44.5
Cash flow from investing activities (27.5)
Net cash from / (used in) investing activities (27.5)
Cash flow from financing activities (9.2)
Net cash from / (used) in financing activities (9.2)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 7.7
Net increase / (decrease) in cash and cash equivalents 7.7
Cash and cash equivalents at the end of the year 55.8
Detailed Income StatementFY 14-15 (in Cr)
164.6
121.0
Total profit before prior period items, exceptional items, extraordinary items and tax 43.6
Exceptional items before tax 0
Total profit before extraordinary items and tax 43.6
Total profit before tax 43.6
13.0
Total profit (loss) for period from continuing operations 30.6
Total profit (loss) for period before minority interest 30.6
Profit (loss) of minority interest 0
Share of profit (loss) of associates (0.6)
Total profit (loss) for period 30.0
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Nominal value of per equity share 0.0
Detailed Balance SheetFY 14-15 (in Cr)
678.3
678.3
Detailed Cash Flow StatementFY 14-15 (in Cr)
Cash flow from operating activities (26.9)
Net cash from / (used in) operating activities (26.9)
Cash flow from investing activities 49.6
Net cash from / (used in) investing activities 49.6
Cash flow from financing activities (6.4)
Net cash from / (used) in financing activities (6.4)
Net increase / (decrease) in cash and cash equivalents before effect of exchange rate changes 16.3
Net increase / (decrease) in cash and cash equivalents 16.3
Cash and cash equivalents at the beginning of the year 31.8
Cash and cash equivalents at the end of the year 48.1
Detailed Income StatementFY 13-14 (in Cr)
115.0
114.8
Total profit before prior period items, exceptional items, extraordinary items and tax 0.2
Exceptional items before tax 58.1
Total profit before extraordinary items and tax 58.3
Extraordinary items before tax 0
Total profit before tax 58.3
15.3
Total profit (loss) for period from continuing operations 43.0
Detailed Balance SheetFY 13-14 (in Cr)
648.7
648.7
Detailed Cash Flow StatementFY 13-14 (in Cr)
Cash flow from operating activities (5.5)
Net cash from/(used in) operating activities (5.5)
Cash flow from investing activities 24.3
Net cash from/(used in) investing activities 24.3
Cash flow from financing activities (8.9)
Net cash from/(used) in financing activities (8.9)
Net increase/(decrease) in cash and cash equivalents before effect of exchange rate changes 9.9
Effect of exchange rate changes on cash and cash equivalents 0
Net increase /(decrease) in cash and cash equivalents 9.9
Cash and cash equivalents at the beginning of the year 7.2
Cash and cash equivalents at the end of the year 17.0

Shareholding Pattern

As of Oct 7, 2025 • Ncdex

Total Shares 89.69M

Top Shareholders

Shareholder Category Shares (Mn) % Holding
NSE Parent Entity 7.60M 8.47%
Life Insurance Corporation of India Parent Entity 5.63M 6.27%
NABARD Parent Entity 5.63M 6.27%
IFFCO Enterprise 5.07M 5.65%
Oman India Joint Investment Fund Fund 5.07M 5.65%

Top Competitors

Similar companies to Ncdex

Indian Energy Exchange

iexindia.com

MCX

mcxindia.com

National Spot Exchange

nationalspotexchange.com

GRD Groupz

grdgroupz.com

AROMA ENTERPRISES

aromaenterprises.in

CapsGold

capsgold.com

Latest News

Updates on Ncdex
Need help? Chat with us! WhatsApp